MDCX: Prakiraan gabungan firma investasi Medicus Pharma Ltd

Logo korporat perusahaan Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd. (MDCX) integrates sustainability principles into the development of dermatological products by minimizing harmful emissions. The business relies on the development of innovative topical therapies for non-melanoma skin cancer, ensuring long-term demand. The current consensus forecast is 204.47. This chart of the current share price reflects the market valuation of this biopharmaceutical enterprise.

MDCX Medicus Pharma Ltd: Target konsensus ing interval 15.11.2024 - 22.10.2026

Rincian analitis perusahaan Medicus Pharma Limited (MDCX)

Analisis umum perusahaan:MDCX medicuspharma.com
Barang unggulan Medicus Pharma Corp

This indicator represents a weighted average fair value estimate of shares based on discounted cash flow forecasts from leading investment houses. Analyzing the analyst consensus chart for MDCX, an investor can identify a long-term price target, which remains stable for Medicus Pharma Ltd. due to the absence of trade barriers and the predictability of clinical trials in developed jurisdictions.